Skip to main content
SpringerLink
Log in

Cost-sharing caps for insulin beneficial for many T1DM patients in the US

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Chua K-P, et al. Potential Change in Insulin Out-of-Pocket Spending Under Cost-Sharing Caps Among Pediatric Patients With Type 1 Diabetes. JAMA Pediatrics : 27 Jul 2020. Available from: URL: http://doi.org/10.1001/jamapediatrics.2020.1065

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cost-sharing caps for insulin beneficial for many T1DM patients in the US. PharmacoEcon Outcomes News 859, 9 (2020). https://doi.org/10.1007/s40274-020-7018-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7018-8

Search

Navigation